Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccines. 1977

F A Ennis, and R E Mayner, and D W Barry, and J E Manischewitz, and R C Dunlap, and M W Verbonitz, and R M Bozeman, and G C Schild

The large, uniformly performed clinical investigations with influenza A/New Jersey vaccines provided an opportunity to correlate results of laboratory tests of vaccine with human reactivity and antibody responses. These vaccines were given to large numbers of subjects under code, and significant differences in immunogenicity and reactivity were observed in unprimed individuals. A single, relatively large dose of intact virus was more immunogenic and reactive than split-virus vaccines in unprimed subjects. Differences in immunogenicity and reactivity in unprimed subjects correlated with the amount of intact virus in the vaccines (measured by column chromatography or electron microscopy) and with the amount of viral hemagglutinin in the vaccine (measured by immunodiffusion), but not with the number of chick cell-agglutinating units.

UI MeSH Term Description Entries
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D009515 New Jersey State bounded on the north by New York and Pennsylvania, on the east by New York and the Atlantic Ocean, on the south by Delaware Bay, and on the west by Pennsylvania.
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D005334 Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. Pyrexia,Fevers,Pyrexias
D006386 Hemagglutination Tests Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed) Hemagglutination Test,Test, Hemagglutination,Tests, Hemagglutination
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F A Ennis, and R E Mayner, and D W Barry, and J E Manischewitz, and R C Dunlap, and M W Verbonitz, and R M Bozeman, and G C Schild
December 1978, The Australian journal of experimental biology and medical science,
F A Ennis, and R E Mayner, and D W Barry, and J E Manischewitz, and R C Dunlap, and M W Verbonitz, and R M Bozeman, and G C Schild
December 1977, The Journal of infectious diseases,
F A Ennis, and R E Mayner, and D W Barry, and J E Manischewitz, and R C Dunlap, and M W Verbonitz, and R M Bozeman, and G C Schild
January 1979, Journal of biological standardization,
F A Ennis, and R E Mayner, and D W Barry, and J E Manischewitz, and R C Dunlap, and M W Verbonitz, and R M Bozeman, and G C Schild
December 1977, The Journal of infectious diseases,
F A Ennis, and R E Mayner, and D W Barry, and J E Manischewitz, and R C Dunlap, and M W Verbonitz, and R M Bozeman, and G C Schild
January 1977, Developments in biological standardization,
F A Ennis, and R E Mayner, and D W Barry, and J E Manischewitz, and R C Dunlap, and M W Verbonitz, and R M Bozeman, and G C Schild
December 1977, The Journal of infectious diseases,
F A Ennis, and R E Mayner, and D W Barry, and J E Manischewitz, and R C Dunlap, and M W Verbonitz, and R M Bozeman, and G C Schild
December 1977, The Journal of infectious diseases,
F A Ennis, and R E Mayner, and D W Barry, and J E Manischewitz, and R C Dunlap, and M W Verbonitz, and R M Bozeman, and G C Schild
December 1977, The Journal of infectious diseases,
F A Ennis, and R E Mayner, and D W Barry, and J E Manischewitz, and R C Dunlap, and M W Verbonitz, and R M Bozeman, and G C Schild
December 1977, The Journal of infectious diseases,
F A Ennis, and R E Mayner, and D W Barry, and J E Manischewitz, and R C Dunlap, and M W Verbonitz, and R M Bozeman, and G C Schild
December 1977, The Journal of infectious diseases,
Copied contents to your clipboard!